Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 6:12:577685.
doi: 10.3389/fnagi.2020.577685. eCollection 2020.

Patterns of CSF Inflammatory Markers in Non-demented Older People: A Cluster Analysis

Affiliations

Patterns of CSF Inflammatory Markers in Non-demented Older People: A Cluster Analysis

Yangdi Peng et al. Front Aging Neurosci. .

Abstract

Objective: In this study, we aimed to examine if patterns of CSF inflammatory markers are correlated with global cognition, episodic memory, hippocampal volume, and CSF AD-related pathologies among non-demented older people.

Methods: We included 217 non-demented older individuals, including 87 subjects with normal cognition (NC) and 130 subjects with mild cognitive impairment (MCI) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. Hierarchical cluster analysis including nine inflammatory markers in CSF [Tumor necrosis factor-α(TNF-α), TNF-R1, TNF-R2, transforming growth factor-β1 (TGF-β1), TGF-β2, TGF-β3, Interleukin-21 (IL-21), IL-6, and IL-7] was conducted.

Results: We identified two clusters among non-demented older people based on nine inflammatory markers in CSF. Compared to the first cluster, the second cluster showed significantly higher levels of CSF inflammatory markers (TNF-R1, TNF-R2, TGF-β1, TGF-β3, and IL-6). Further, the second cluster was also associated with higher levels of t-tau and p-tau levels in CSF.

Conclusion: We observed a subgroup of non-demented older people characterized by increased levels of inflammatory markers in CSF. Further, this subgroup showed higher levels of t-tau and p-tau levels in CSF.

Keywords: Alzheimer’s disease; cluster analysis; cytokines; inflammation; tau.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Dendrogram of non-demented older people based on nine CSF inflammatory proteins.
FIGURE 2
FIGURE 2
CSF tau pathologies between clusters. (A) There was a significant difference in CSF t-tau levels between two clusters (p = 0.03). (B) There was a marginally significant difference in CSF p-tau levels between two clusters (p = 0.05).

Similar articles

Cited by

References

    1. Bettcher B. M., Kramer J. H. (2014). Longitudinal inflammation, cognitive decline, and Alzheimer’s disease: a mini-review. Clin. Pharmacol. Ther. 96 464–469. 10.1038/clpt.2014.147 - DOI - PMC - PubMed
    1. Blum-Degen D., Müller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. (1995). Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer’s and de novo Parkinson’s disease patients. Neurosci. Lett. 202 17–20. 10.1016/0304-3940(95)12192-7 - DOI - PubMed
    1. Buchhave P., Zetterberg H., Blennow K., Minthon L., Janciauskiene S., Hansson O. (2010). Soluble TNF receptors are associated with AÎ?? metabolism and conversion to dementia in subjects with mild cognitive impairment. Neurobiol. Aging 31 1877–1884. - PubMed
    1. Calsolaro V., Edison P. (2016). Neuroinflammation in Alzheimer’s disease: current evidence and future directions. Alzheimers Dement. 12 719–732. 10.1016/j.jalz.2016.02.010 - DOI - PubMed
    1. Craig-Schapiro R., Perrin R. J., Roe C. M., Xiong C., Carter D., Cairns N. J., et al. (2010). YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer’s disease. Biol. Psychiatry 68 903–912. 10.1016/j.biopsych.2010.08.025 - DOI - PMC - PubMed

LinkOut - more resources